Skip to main content
SpringerLink
Log in

Type 2 atrophy in a pentazocine addicted patient

  • Case Reports
  • Published:
The Italian Journal of Neurological Sciences Aims and scope Submit manuscript

Abstract

A case of a 33-year-old pentazocine-addicted man (450 mg daily) is described. Histochemical and quantitative histographic analyses of the muscle biopsy disclosed type 2 atrophy.

We consider that this indicates that there is a generalized toxic effect of pentazocine.

Sommario

Viene descritto un caso di abuso di pentazocine (450 mg die) in un uomo di 33 a. Lo studio bioptico muscolare dal punto di vista istochimico e istografico quantitativo ha dimostrato una atrofia delle fibre del tipo 2. Si suggerisce la possibilità di un danno tossico generalizzato da parte della pentazocina.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Burnam H. A.:Pentazocine-induced fibrous myopathy. J.A.M.A., 234: 913, 1975.

    Google Scholar 

  2. Dubowitz V., Brooke M. H.:Muscle biopsy: a modern approach. Saunders, 1973.

  3. Fleiss D.:Pentazocine-induced fibrous myopathy. J.A.M.A., 232: 1128, 1975.

    Google Scholar 

  4. Levin B. E., Engel W. K.:Iatrogenic muscle fibrosis. J.A.M.A., 234: 622–624, 1975.

    Google Scholar 

  5. Oh S. J.:Experimental pentazocine-induced fibrous myopathy. Alab. J. Med. Sci., 14: 64–67, 1977.

    CAS  Google Scholar 

  6. Parks D. L., Perry H. O., Muller S. A.:Cutaneous complications of pentazocine injections. Arch. Derm., 104: 231–235, 1971.

    Article  CAS  PubMed  Google Scholar 

  7. Schlicher J. E., Zuelcke R. L., Lynch P. J.:Local changes at the site of pentazocine injection. Arch. Derm., 104: 90–91, 1971.

    Article  CAS  PubMed  Google Scholar 

  8. Swanson D. W., Weddige R. L., Morse R. M.:Hospitalized pentazocine abusers. Mayo Clin. Proc., 48: 83–93, 1973.

    Google Scholar 

  9. Steiner J. C., Winkelman A. C., de Jesus P. V.:Pentazocine-induced myopathy. Arch. Neurol., 28: 408–409, 1973.

    CAS  PubMed  Google Scholar 

  10. Winfield J. B., Greer K.:Cutaneous complications of parenterally administered pentazocine. J.A.M.A., 225: 189–190, 1973.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisione Neurologica, Università di Milano, Via F. Sforza 35, 20122, Milano, (Italia)

    Mariani C., Albizzati M. G., Bassi S. & Meola G.

  2. Ospedale di Circolo, Cassano d'Adda, Via F. Sforza 35, 20122, Milano, (Italia)

    Boni S.

Authors
  1. Mariani C.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Albizzati M. G.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Boni S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bassi S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Meola G.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mariani, C., Albizzati, M.G., Boni, S. et al. Type 2 atrophy in a pentazocine addicted patient. Ital J Neuro Sci 1, 113–118 (1979). https://doi.org/10.1007/BF02336853

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02336853

Key-Words

Search

Navigation